These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627 [TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Arkenau HT; Bermann A; Rettig K; Strohmeyer G; Porschen R; Ann Oncol; 2003 Mar; 14(3):395-9. PubMed ID: 12598344 [TBL] [Abstract][Full Text] [Related]
8. A systematic overview of chemotherapy effects in colorectal cancer. Ragnhammar P; Hafström L; Nygren P; Glimelius B; Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518 [TBL] [Abstract][Full Text] [Related]
11. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775 [TBL] [Abstract][Full Text] [Related]
12. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. Wolmark N; Rockette H; Mamounas E; Jones J; Wieand S; Wickerham DL; Bear HD; Atkins JN; Dimitrov NV; Glass AG; Fisher ER; Fisher B J Clin Oncol; 1999 Nov; 17(11):3553-9. PubMed ID: 10550154 [TBL] [Abstract][Full Text] [Related]
13. North Central Cancer Treatment Group--Mayo Clinic trials in colon cancer. O'Connell MJ Semin Oncol; 2001 Feb; 28(1 Suppl 1):4-8. PubMed ID: 11273589 [TBL] [Abstract][Full Text] [Related]
14. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973 [TBL] [Abstract][Full Text] [Related]
15. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group. Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT Ann Oncol; 2000 May; 11(5):547-52. PubMed ID: 10907947 [TBL] [Abstract][Full Text] [Related]
16. Retrospective evaluation of toxicity in three different schedules of adjuvant chemotherapy for patients with resected colorectal cancer. TTD Spanish Cooperative Group. Sastre J; Navarro M; Aranda E; Fonseca E; Checa T; Alonso MC; Gallen M; Camps C; Antón A; Díaz-Rubio E Oncol Rep; 1999; 6(6):1421-4. PubMed ID: 10523723 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group. Figueredo A; Fine S; Maroun J; Walker-Dilks C; Wong S Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754 [TBL] [Abstract][Full Text] [Related]
18. Future directions in the adjuvant treatment of colon cancer. Mamounas EP; Wieand HS; Jones J; Wickerham DL; Wolmark N Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):44-7. PubMed ID: 9348567 [TBL] [Abstract][Full Text] [Related]
19. [Progression of adjuvant chemotherapy for colon cancer]. He YJ; Dong QM; Li YH Ai Zheng; 2005 Dec; 24(12):1546-9. PubMed ID: 16351811 [TBL] [Abstract][Full Text] [Related]
20. [Recent advances in adjuvant chemotherapy in colonic cancers]. Ducreux M; Rougier P Rev Med Interne; 1997; 18 Suppl 4():379s-385s. PubMed ID: 9365716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]